Emergent BioSolutions Inc.EBSNYSE
Loading
Profit from core business operations before interest and taxes
5Y CAGR
-24.1%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $110.20M | +201.4% |
| 2024 | $-108.70M | +85.0% |
| 2023 | $-726.40M | -327.3% |
| 2022 | $-170.00M | -149.8% |
| 2021 | $341.40M | -22.1% |
| 2020 | $438.50M | +284.3% |
| 2019 | $114.10M | +27.1% |
| 2018 | $89.80M | -27.8% |
| 2017 | $124.30M | +17.8% |
| 2016 | $105.50M | - |